Why this grouping
MONDO alignment & provenance
The grouping concept corresponds exactly to the MONDO carnitine palmitoyl transferase deficiency class, whose descendants are the two members and the clinical forms of CPT II deficiency. CPT1C-related disease is not a descendant of this class, matching its exclusion here.
Membership criteria
- AND
- OR
A carnitine palmitoyltransferase gene is the causal locus.
- HAS GENE
CPT1A hgnc:2328
Deficiency of liver-type CPT1 (CPT1A).
- HAS GENE
CPT2 hgnc:2330
Deficiency of CPT II (CPT2).
- HAS GENE
CPT1A hgnc:2328
- HAS BIOLOGICAL PROCESS
Carnitine shuttle GO:0006853
The carnitine shuttle is impaired.
- OR
A carnitine palmitoyltransferase gene is the causal locus.
Coverage and gaps
Exact MONDO scope: MONDO:0700284 · carnitine palmitoyl transferase deficiency Completeness is counted over rows inside this exact MONDO scope that are listed in this grouping. Finer MONDO descendants under already-covered DisMech concepts are suppressed (3).
| Status | DisMech entry | MONDO concept | In DisMech | Has MONDO ID | In grouping MONDO | Member state | Conditions satisfied | C1.1 Deficiency of liver-type CPT1 (CPT1A). hgnc:2328 | C1.2 Deficiency of CPT II (CPT2). hgnc:2330 | C1.3 The carnitine shuttle is impaired. GO:0006853 |
|---|---|---|---|---|---|---|---|---|---|---|
| listed in scope |
Carnitine Palmitoyltransferase 1A Deficiency
DISEASE
Differentiating mechanismThe block is at the outer mitochondrial membrane, before acylcarnitine formation: long-chain acyl-CoAs cannot be converted to acylcarnitines, so free carnitine is high and long-chain acylcarnitine species are low - the inverse of the CPT II signature. The phenotype is hepatic (fasting-provoked hypoketotic hypoglycemia and hepatic encephalopathy), with a distinctive arctic founder allele (P479L); there is no rhabdomyolysis-dominant adult form.
CPT1A hgnc:2328
|
carnitine palmitoyltransferase 1A deficiency
MONDO:0009705
|
yes | yes | yes | listed | satisfied | SATISFIED | NOT SATISFIED | SATISFIED |
| listed in scope |
Carnitine Palmitoyltransferase II Deficiency
DISEASE
Differentiating mechanismThe block is at the inner mitochondrial membrane, after acylcarnitine import: long-chain acylcarnitines accumulate (elevated C16, C18:1, and C18:2 species, high (C16+C18:1)/C2 ratio) and are themselves membrane-toxic. The clinical spectrum spans lethal neonatal and severe infantile hepatocardiomuscular forms through the common adult myopathic form with exercise-, fasting-, or illness-triggered rhabdomyolysis and myoglobinuria - the presentation that most sharply separates it from CPT1A deficiency.
CPT2 hgnc:2330
|
carnitine palmitoyltransferase II deficiency
MONDO:0015515
|
yes | yes | yes | listed | satisfied | NOT SATISFIED | SATISFIED | SATISFIED |
Source
View YAML on GitHubRaw YAML
name: Carnitine Palmitoyltransferase Deficiencies
display_name: Carnitine palmitoyltransferase (CPT) deficiencies
creation_date: "2026-08-28T00:00:00Z"
description: >-
The carnitine palmitoyltransferase deficiencies are the two inherited
defects of the carnitine shuttle's transferase steps: CPT1A deficiency,
which blocks formation of long-chain acylcarnitines at the outer
mitochondrial membrane, and CPT II deficiency, which blocks their
reconversion to acyl-CoAs at the inner membrane. Both cut off mitochondrial
long-chain fatty acid beta-oxidation and therefore fail the same
physiological stress test - fasting, intercurrent illness, or prolonged
exercise, when tissues must switch to fat as fuel - but they sit on
opposite sides of the shuttle and leave opposite acylcarnitine signatures.
grouping_basis:
- SHARED_MECHANISM
- SHARED_GENE_FAMILY
grouping_rationale: >-
Grouped on the shared mechanism (loss of a carnitine palmitoyltransferase
step of the carnitine shuttle, cutting off long-chain fatty acid
beta-oxidation) and on the paralogous gene family that names the group.
The members are deliberately kept as separate Disease entries because the
two blocks are biochemically and clinically distinct: CPT1A deficiency
presents as hypoketotic hypoglycemic hepatic encephalopathy of infancy
with elevated free carnitine and low long-chain acylcarnitines, and has no
myopathic form; CPT II deficiency accumulates long-chain acylcarnitines
and spans three forms, including the common adult myopathic form with
exercise-induced rhabdomyolysis - a presentation CPT1A deficiency does not
produce. The newborn-screening flags run in opposite directions (high C0
with low C16/C18 species versus elevated C16/C18:1/C18:2 acylcarnitines), so
merging the two entries would blur exactly the biochemistry that
distinguishes them at diagnosis.
Boundary notes: the neuronal paralog CPT1C is excluded - its variants
cause a hereditary spastic paraplegia (curated separately as
CPT1C-Related Hereditary Spastic Paraplegia) with no fatty acid oxidation
failure phenotype, so gene-family kinship alone does not admit it.
Carnitine-acylcarnitine translocase (SLC25A20) deficiency shares the
shuttle and much of the clinical picture but is not a carnitine
palmitoyltransferase deficiency; it belongs beside this grouping in any
future carnitine-shuttle or long-chain FAO disorder grouping, not inside
it.
mappings:
mondo_mappings:
- term:
id: MONDO:0700284
label: carnitine palmitoyl transferase deficiency
mapping_predicate: skos:exactMatch
mapping_source: MONDO
mapping_justification: >-
The grouping concept corresponds exactly to the MONDO carnitine
palmitoyl transferase deficiency class, whose descendants are the two
members and the clinical forms of CPT II deficiency. CPT1C-related
disease is not a descendant of this class, matching its exclusion
here.
membership_criteria:
- description: >-
Every member is caused by deficiency of a carnitine palmitoyltransferase
of the mitochondrial carnitine shuttle (CPT1A or CPT2), impairing the
shuttle and long-chain fatty acid beta-oxidation.
criteria_semantics: NECESSARY
logic:
operator: AND
operands:
- operator: OR
description: A carnitine palmitoyltransferase gene is the causal locus.
operands:
- criterion_predicate: HAS_GENE
description: Deficiency of liver-type CPT1 (CPT1A).
gene:
preferred_term: CPT1A
term:
id: hgnc:2328
label: CPT1A
- criterion_predicate: HAS_GENE
description: Deficiency of CPT II (CPT2).
gene:
preferred_term: CPT2
term:
id: hgnc:2330
label: CPT2
- criterion_predicate: HAS_BIOLOGICAL_PROCESS
description: The carnitine shuttle is impaired.
biological_processes:
- preferred_term: Carnitine shuttle
term:
id: GO:0006853
label: carnitine shuttle
modifier: DECREASED
members:
- member: Carnitine Palmitoyltransferase 1A Deficiency
member_type: DISEASE
display_name: CPT1A deficiency (outer-membrane block)
differentiating_mechanisms:
- description: >-
The block is at the outer mitochondrial membrane, before acylcarnitine
formation: long-chain acyl-CoAs cannot be converted to acylcarnitines,
so free carnitine is high and long-chain acylcarnitine species are low
- the inverse of the CPT II signature. The phenotype is hepatic
(fasting-provoked hypoketotic hypoglycemia and hepatic
encephalopathy), with a distinctive arctic founder allele (P479L);
there is no
rhabdomyolysis-dominant adult form.
gene:
preferred_term: CPT1A
term:
id: hgnc:2328
label: CPT1A
- member: Carnitine Palmitoyltransferase II Deficiency
member_type: DISEASE
display_name: CPT II deficiency (inner-membrane block)
differentiating_mechanisms:
- description: >-
The block is at the inner mitochondrial membrane, after acylcarnitine
import: long-chain acylcarnitines accumulate (elevated C16, C18:1,
and C18:2 species, high (C16+C18:1)/C2 ratio) and are themselves
membrane-toxic. The clinical spectrum spans lethal neonatal and
severe infantile hepatocardiomuscular forms through the common adult
myopathic form with exercise-, fasting-, or illness-triggered
rhabdomyolysis and myoglobinuria - the presentation that most sharply
separates it from CPT1A deficiency.
gene:
preferred_term: CPT2
term:
id: hgnc:2330
label: CPT2
notes: >-
Created from the stub-queue lump/split review: the seeded stub for
MONDO:0700284 (carnitine palmitoyl transferase deficiency) resolved as
entry_type GROUPING because both constituent diseases are already curated
as separate entries and the label names their union - two paralogous
transferase deficiencies on opposite sides of one shuttle, with opposite
acylcarnitine signatures. Both members annotate GO:0006853 (carnitine
shuttle), so the biological-process leaf is machine-checkable.